Immunotoxicity and Immunogenicity

Research platforms

Non-clinical Safety Evaluation and Research Platform

PLATFORM

ABOUT US SERVICES PLATFORM CAREERS NEWS INFORMATION DISCLOSURE CONTACT US

Non-clinical Safety Evaluation and Research Platform

Non-clinical Pharmacodynamic Research Platform Non-clinical Pharmacokinetic Research Platform Non-clinical Safety Evaluation and Research Platform

Immunotoxicity and Immunogenicity

Safety pharmacology General toxicology Genetic toxicology Developmental and Reproductive Toxicity Immunotoxicity and Immunogenicity Carcinogenic Testing Safety Tests for Drug Products Safety Evaluation of Inhalation Preparations Dependence experiment Regulatory Support Services Pathology and Clinical Pathology

Immunotoxicity and Immunogenicity Download PDF

Safety evaluations also focus on immune system interactions, including immunotoxicity assessments (e.g., hematology, immunoglobulin levels), pathology studies, and immunogenicity testing.

Key Studies:
-T-cell-dependent antibody response (TDAR)
-Immunophenotyping and analysis
-Immunogenicity studies

For more information, please contact us.

+86-021-60211999

MESSAGE

Business requirements

The content of the business requirements drop-down menu is as follows

Early-stage Druggability Assessment Pharmacodynamics Nonclinical pharmacokinetics Toxicology (Safety evaluation) Clinical biological sample testing Biomarkers and translational research Global registration and consultation services

Consultation product molecular type

Message content

Shanghai Headquarters

Address: 199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, China

Postcode: 201203

Tel: +86-21-60211999
Contact us

services@innostarbio.com
投资者关系

86-021-xxxxxxx

Scan the QR code
Subscription to our Wechat account